The Father Of Medical Cannabis Research Celebrates His 90th Birthday At CannX

CannX 2020 Virtual Conference, 26 October 2020 Online

ISRAEL:  CannX has proven itself time and time again as the central meeting point for exploring the latest developments in medical cannabis. With top quality of the conference program and the leading international speakers, CannX Virtual 2020 will provide the latest in scientific research, agricultural practices and innovation, and business opportunities. Cannabis sativa has a long history as a medicinal plant and has shown therapeutic effect in patients with pain, nausea, posttraumatic stress disorder, cancer, epilepsy, glaucoma and many more conditions.

“I believe cannabinoids represent a medical treasure waiting to be discovered,” said Prof. Raphael Mechoulam, Conference President.

This year, CannX will include a special celebration in honor of Raphael Mechoulam, the Father of Medical Cannabis Research. Since the inception of his research in the 60s, Professor Mechoulam has been nominated for over 25 academic awards, including the Heinrich Wieland Prize (2004), an Honorary doctorate from Complutense University (2006), the Israel Prize in Exact Sciences – _Chemistry (2000), the Israel Chemical Society Prize for excellence in research (2009) and EMET Prize in Exact Sciences – Chemistry (2012). The honorary session will include a one-on-one interview of Prof. Mechoulam by Dr. Dedi Meiri and several surprises.

The CannX platform is dedicated to advancing scientific knowledge and practice in the emerging field of medical cannabis. With a program designed to showcase recent research and analyze real-world applications, the conference provides a unique opportunity for scientists, clinical researchers, start-ups, and established industry companies to form new collaborations and discuss the potential impact of the latest findings.

CannX 2020 will be a virtual conference, providing access to content whenever and wherever the attendees are located, thus ensuring interaction with a uniquely diverse professional audience base. The program has been submitted to the European Accreditation Council for Continuing Medical Education (EACCME) and is pending CME accreditation. Session highlights include:

  • Women in the Forefront of Cannabis Innovation
  • The Interplay of Science, Business and Law
  • Cannabinoids and the Elderly
  • Medical Cannabis and the Role of Pharmacists: The Israeli Experience
  • COVID-19, CBD and Cannabis

View the full programs here: